ライフサイエンスコーパス: clinician

1 espectively; 46% vs 55% [P = .02] for breast clinicians).

2 al risk (mean, 1858 beneficiaries; mean, 269 clinicians).

3 n 1000 consecutive families seen by a single clinician.

4 abetes, especially for the diagnosis made by clinician.

5 hinitis (NAR) has become a challenge for the clinician.

6 management challenges for the cardiovascular clinician.

7 ues provide complementary information to the clinician.

8 dysfunction (PGD) remains a research gap for clinicians.

9 rmation about prognosis from palliative care clinicians.

10 the aim of providing guidance for transplant clinicians.

11 stemic effects have caused concern from some clinicians.

12 tated in the literature and overestimated by clinicians.

13 get audience for this guideline includes all clinicians.

14 mains unpredictable and challenging for most clinicians.

15 lasma cortisol of < 10 mug/dL may be used by clinicians.

16 d in a vGMS note, which could be seen by all clinicians.

17 (4 reviews/overviews); and higher age of the clinician (1 overview).

18 sk only (mean, 3675 beneficiaries; mean, 370 clinicians), 102 were high social risk only (mean, 1635

19 l risk) (mean, 7909 beneficiaries; mean, 320 clinicians), 128 were high medical risk only (mean, 3675

20 if indicated, HBAT release, are available to clinicians 24/7 through their state health department in

21 A total of 184 clinicians (64 physicians, 94 nurses, and 14 residents).

22 To provide clinicians a means of interpreting individual FFR-CT res

23 RATIONALE: Information from clinicians about the expected course of the patient's il

24 Clinician abstractors identified potential errors and AE

25 nally, the authors offer recommendations for clinicians actively initiating and up-titrating beta-blo

26 outcome measures were the suicide items from clinician-administered (the Montgomery-Asberg Depression

27 suicidal ideation significantly on both the clinician-administered and self-report outcome measures.

28 the Positive and Negative Syndrome Scale and Clinician-Administered Dissociative Symptoms Scale.

29 TSD was assessed at each assessment with the Clinician-Administered PTSD Scale.

30 tamate+glutamine (Glx) were measured using a clinician-administered questionnaire, fMRI during perfor

31 Barriers to clinician adoption or adherence to guidelines included t

32 Agreement with clinician AE reports was analyzed with weighted kappa st

33 Clinicians, afraid of missing intracranial injuries, lib

34 OCT and photograph reading by clinicians agree poorly in CDR assessment.

35 Most clinicians agree that management of HAA is highly variab

36 For patients, laboratories, and clinicians alike, nonfasting lipid profiles represent a

37 on the part of investigators, patients, and clinicians alike.

38 ICU clinicians also should be knowledgeable of their state's

39 car) to 15 (worst possible scar), based on 6 clinician and 2 patient items was used.

40 tched analyses to account for confounding by clinician and by patient-level characteristics, respecti

41 Diagnoses made by expert clinician and by the C-PASS were compared.

42 s to better understand any given task that a clinician and his or her staff may be required to perfor

43 be discussed with patients and may influence clinician and patient choice of second-line therapy.

44 ht additional weeks at the discretion of the clinician and patient.

45 lack of communication between the referring clinician and radiologist leads to innumerable unnecessa

46 (2) Does teledermatology save clinician and/or patient time, compared with usual care?

47 entia is a priority for patients, carers and clinicians and a policy priority.

48 ed by at least 2 infectious diseases-trained clinicians and according to institutional guidelines.

49 close cooperation and communication between clinicians and basic scientists, which resulted in the e

50 to assess moral distress among critical care clinicians and develop tailored interventions addressing

51 This can provide data to clinicians and doctors concerning cytokines secretion at

52 This study can assist clinicians and drug developers in deciding which therano

53 Clinicians and genetic researchers are being faced with

54 opulation are provided to offer guidance for clinicians and identify gaps in knowledge for future inv

55 asily understandable and useful baseline for clinicians and managers.

56 e Network, (2) the locations of primary care clinicians and ophthalmologists across the state, and (3

57 an rights approach advanced here can provide clinicians and other key stakeholders with concrete insi

58 eatment team should educate the primary care clinicians and patients about the type(s) of treatment r

59 vering solid clinical molecular diagnosis to clinicians and patients and improving the standard care

60 Clinicians and patients must have accurate and realistic

61 Clinicians and patients now frequently face challenging

62 equate response to nonpharmacologic therapy, clinicians and patients should consider pharmacologic tr

63 2: For patients with chronic low back pain, clinicians and patients should initially select nonpharm

64 n improve over time regardless of treatment, clinicians and patients should select nonpharmacologic t

65 If pharmacologic treatment is desired, clinicians and patients should select nonsteroidal anti-

66 We encourage clinicians and patients to consider treatment with syste

67 The method allows both clinicians and patients to have a more nuanced view of t

68 the initial 6 months, it is not possible for clinicians and patients to weigh risks and benefits in a

69 Clinicians and policy makers should consider these alter

70 features of BCC in the very elderly to guide clinicians and policy makers.

71 Clinicians and public health departments preparing for a

72 rauma during childhood might usefully inform clinicians and public health professionals regarding the

73 his condition should be kept in mind by both clinicians and radiologists and looked for in order to p

74 from a broad set of stakeholders, including clinicians and researchers from across multiple discipli

75 models and an online risk calculator provide clinicians and researchers with a simple tool to screen

76 ger provide the most up-to-date guidance for clinicians and researchers.

77 offer a survey of the latest literature for clinicians and scientists alike, providing a list of imp

78 CHD clinicians and scientists are interested not only in car

79 econd EMBO Workshop on AIDS-Related Mycoses, clinicians and scientists from around the world reported

80 These findings offer clinicians and stakeholders a comprehensive assessment a

81 sk only (mean, 1635 beneficiaries; mean, 284 clinicians), and 122 were high medical and social risk (

82 To (1) identify patient, clinician, and hospital characteristics associated with

83 amily reporting, (2) reported by families vs clinicians, and (3) reported by families vs hospital inc

84 n mean scores between ICUs, between types of clinicians, and between patients' clinical status and mo

85 Participants, clinicians, and investigators were blinded to group assi

86 laboration among systems redesign personnel, clinicians, and surgical staff to reduce systemic ineffi

87 ration has captured the minds of scientists, clinicians, and the public.

88 get audience for this guideline includes all clinicians, and the target patient population includes a

89 get audience for this guideline includes all clinicians, and the target patient population includes a

90 get audience for this guideline includes all clinicians, and the target patient population includes a

91 Clinicians are also better informed to determine risk as

92 In the hopes of improving outcomes, clinicians are increasingly turning to percutaneous left

93 ar mortality in the hemodialysis population, clinicians are obligated to explore whether factors rela

94 ICU clinicians are primarily involved in organ donation afte

95 Debate continues among clinicians as to both the clinical relevance of subclini

96 ished reports to provide balanced advice for clinicians as well as suggestions for future trials.

97 Treating clinicians assessed outcomes of ICD diagnosis and functi

98 Trained clinicians assessed patients at enrolment to the cohort,

99 Secondary outcomes were clinician-assessed remission of insomnia; sleep quality;

100 in adulthood and provide a framework for the clinician assessing a patient presenting with predominan

101 e assigned to the intervention met with a PC clinician at least once per month until death, whereas t

102 Given that clinician-based assessments are not known to be strong p

103 tion of these response patterns may help all clinicians better communicate their support to patients

104 has recognized their importance not only to clinicians but also to epidemiologists, statisticians, h

105 entia (bvFTD) poses a daunting challenge for clinicians but will be critical for the success of disea

106 density of ophthalmologists and primary care clinicians by zip code relative to US Census Urban Areas

107 and numerous development programs under way, clinicians can expect to see many new biosimilars come o

108 often unrealistic, posing challenges for the clinicians caring for them.

109 Recommendation 1: ACP recommends that clinicians choose corticosteroids, nonsteroidal anti-inf

110 Clinicians completed written surveys that assessed attit

111 editorializations, answering for the patient/clinician, confessions, and patient advocacy.

112 for suicidal behavior was derived by expert clinician consensus review of 2,700 narrative EHR notes

113 Recommendation 2: ACP recommends that clinicians consider adding either a sulfonylurea, a thia

114 ecommendation 3: ACP and AAFP recommend that clinicians consider initiating or intensifying pharmacol

115 ecommendation 2: ACP and AAFP recommend that clinicians consider initiating or intensifying pharmacol

116 findings are an important starting point for clinicians considering the introduction of one of the ru

117 Overall, HIT'nDRIVE may help clinicians contextualize massive multiomics data in ther

118 h to data science, whereby basic scientists, clinicians, data analysts, and epidemiologists work toge

119 These findings can help clinicians decide on the optimal castration strategy for

120 in clinical practice and inform patient and clinician decision making.

121 This approach can help clinicians determine appropriate, personalized target IO

122 Site clinicians diagnosed 2052 infections during the 3-year s

123 was most associated with 2-year incidence of clinician-diagnosed DED.

124 ral population study, those with AD reported clinician-diagnosed depression and anxiety more often th

125 Information on history of clinician-diagnosed rosacea and year of diagnosis was co

126 y participants responded to a question about clinician-diagnosed vitiligo and year of diagnosis (2001

127 Most clinicians do not adhere to IDSA guidelines, delaying di

128 However, narrative notes written by clinicians do not capture first-hand the patients' own e

129 of spirituality for patients, families, and clinicians during end-of-life care in the ICU are suppor

130 Best Practice Advice 6: Clinicians embarking on incorporating EBTs into their cl

131 A total of 351 patient-clinician encounters with 184 different patients.

132 validation through larger scale patient and clinician engagement to determine whether it is preferab

133 uently, biomarker use may be challenging for clinicians, especially in patients with mild cognitive i

134 Clinicians evaluating high-altitude travelers who report

135 gies are often not addressed by primary care clinicians, even in older patients with recent fractures

136 ry given widespread internet access and thus clinician exposure to variable quality medical informati

137 hese strategies should help ICU managers and clinicians facilitate robust communication with patients

138 rm will greatly benefit both researchers and clinicians for interrogating mechanisms of mutation-depe

139 ract infections can be diagnosed clinically, clinicians frequently order tests to identify the specif

140 The project has generated clinician-friendly dosing algorithms and pointed to circ

141 younger (total 3902 patient-days) and their clinicians from December 2014 to July 2015 in 4 US pedia

142 On the basis of this review, clinicians from surgery, anesthesia, critical care, and

143 ssessing serial ventilator settings may help clinicians identify candidates for early antibiotic disc

144 uld serve as an early warning system to help clinicians identify high-risk patients for further scree

145 ted method to combine risk factors and guide clinicians in assessing seizure risk.

146 using standardised criteria for referral to clinicians in Basse and Bansang.

147 se from application of the rule by different clinicians in different environments.

148 A challenge for clinicians in emergency departments (EDs) is rapid ident

149 This may aid clinicians in presurgical evaluation by providing a tool

150 hat the risk factors we identified can guide clinicians in providing adequate care for patients in th

151 the two treatments were sufficient to guide clinicians in their choice of one drug over the other.

152 These data may inform clinicians in understanding why a prescribed inhaler is

153 All clinicians, including pediatricians, can counsel about L

154 ecommendation 1: ACP and AAFP recommend that clinicians initiate treatment in adults aged 60 years or

155 ns to promoting exercise through the patient-clinician interaction must be addressed.

156 tomated pupillometry results were blinded to clinicians involved in patient care.

157 patients are selected appropriately, and the clinician is aware of the many unique aspects in managem

158 iagnosed and unreported, and awareness among clinicians is low.

159 clinician skepticism (5 reviews/overviews); clinician knowledge of guidelines (4 reviews/overviews);

160 a well-established electronic health record, clinician laboratory data retrieval and communication du

161 ology lies in integrative research, in which clinicians, laboratory scientists, and data analysts com

162 n primary and urgent care settings, may help clinicians make a provisional diagnosis of gout.

163 nitis in persons aged 12 years or older, the clinician may recommend the combination of an intranasal

164 xt, we discuss the use of biomarkers and how clinicians may be able to use them in the future to pred

165 Using IL-10 as an initial biomarker, clinicians may consider more aggressive antimicrobials f

166 Although some clinicians may have the technical training for such surg

167 Clinicians may help protect patients after discharge by

168 In the wake of this rapid growth, clinicians may lack sufficient information about tCS to

169 al evidence of consciousness at the bedside, clinicians may render an inaccurate prognosis, increasin

170 e achieved via the coordinated networking of clinicians, microbiologists, natural product chemists, a

171 of both benign and malignant hematology, but clinicians must carefully consider these core ethical is

172 Clinicians must understand the appropriate and safe use

173 romboembolism (VTE) often is considered, but clinicians need precise data on cancer prevalence, risk

174 Clinicians need to be aware that most patients with OH a

175 ntification of HEs becomes crucial and hence clinicians now seek to measure the area of HEs in the di

176 emand creation and uptake of test results by clinicians, nurses, and patients, which will be vital in

177 Recommendation 3: ACP recommends that clinicians offer pharmacologic treatment with bisphospho

178 If clinically appropriate, clinicians often manage this disorder by lowering the do

179 Clinicians often risk stratify young febrile infants for

180 institution's training, and only 26.5% had a clinician on their graduate advisory committee.

181 Purpose To provide guidance to oncology clinicians on how to use effective communication to opti

182 Limited evidence is available to guide clinicians on which post-SVR patients should be monitore

183 am-based approach that includes primary care clinicians, oncology specialists, otolaryngologists, den

184 (SQDES) as a previous diagnosis of DED by a clinician or "often" or "constant" symptoms of dryness a

185 nterpreted speech was compared with original clinician or family speech using the qualitative researc

186 tronic medical records capable of supporting clinician order entry and of clinical decision support t

187 Patients and all clinicians other than the DBS programming nurse were mas

188 ve interviews with 76 family members and 150 clinicians participating in the Three Wishes Project.

189 g of asthma-COPD overlap was discussed among clinicians, pathologists, radiologists, epidemiologists,

190 ss a heart-brain team approach that includes clinician-patient shared decision making for the use of

191 se awareness of the impact of glaucoma among clinicians, patients and their families, for a better un

192 e evidence-based recommendations to oncology clinicians, patients, family and friend caregivers, and

193 ving all stakeholders including researchers, clinicians, patients, funding bodies and policymakers.

194 substantial effects on provision of care as clinicians, patients, regulators, and dialysis organizat

195 dards of Medical Care in Diabetes to provide clinicians, patients, researchers, payers, and other int

196 The intended users of this action plan are clinicians, patients, scientists, industry partners, gov

197 rch may contribute to obtaining answers that clinicians perceive they need and may minimize research

198 rumental variable analysis that incorporated clinician preference-based, institutional variation in N

199 Recommendation 1: ACP recommends that clinicians prescribe metformin to patients with type 2 d

200 However, clinicians rarely advocate breathing retraining and acce

201 Quick Inventory of Depressive Symptomatology-Clinician Rated [QIDS-C16] score </=5 at 2 consecutive v

202 rated social communication abnormalities and clinician-rated diagnostic certainty about ASD) in later

203 tology (QIDS-SR) scale and 14 items from the clinician-rated Hamilton Depression (HAM-D) rating scale

204 inistration early after trauma on subsequent clinician-rated PTSD symptoms.

205 These clinicians recorded clinical findings and applied standa

206 ogical tissues raised expectations among the clinicians regarding possibility to distinguish between

207 ence of resistance, SPVs and RPVs can inform clinicians regarding the best choice for empiric antimic

208 spondence analysis to describe categories of clinicians regarding their perceptions and experience of

209 ing purchase among laboratory professionals, clinicians, regulators, and even patients.

210 Development Forum consisting of scientists, clinicians, regulators, and industry representatives has

211 ective communication to optimize the patient-clinician relationship, patient and clinician well-being

212 reduce structural barriers, improve patient-clinician relationships, and enhance patient knowledge a

213 iety symptoms (measured by child, parent, or clinician), remission, response, and adverse events.

214 Families and clinicians reported similar rates of errors (10.0 vs 12.

215 Patient-reported outcomes confirmed clinician reporting that the investigational agent was w

216 ical records, hospital incident reports, and clinician reports as well as weekly and discharge Family

217 hairs was to focus on developing skills as a clinician, researcher, and educator ("triple threat").

218 care is offered as a suggested approach for clinicians, researchers, and policy-makers.

219 ith antibiotics prescribed at the individual clinician's discretion.

220 ion with support and social network size and clinician's evaluation of the degree of support received

221 Significant differences exist among ICU clinician's perceptions of organ donation.

222 are the same values, nor does it demand that clinicians sacrifice their own codes of conduct out of c

223 Aarhus, Denmark) in December 2015 by leading clinicians, scientists and industry representatives in t

224 ht of recent clinical trial data, could help clinician-scientists generate novel therapeutic approach

225 The USPSTF recommends that clinicians screen for obesity in children and adolescent

226 ACP and AAFP recommend that clinicians select the treatment goals for adults aged 60

227 vir 100 mg, twice per day) plus two or three clinician-selected NRTIs (protease inhibitor plus NRTI g

228 -boosted lopinavir) with two to three NRTIs (clinician-selected, without resistance testing); or with

229 echocardiographic study was performed at the clinician set RR interval and at heart rates from 70 to

230 ted laws should not be viewed as barriers to clinicians sharing information with ICU patients and the

231 Meanwhile, clinicians should aggressively incorporate treatment to

232 Finally, ICU clinicians should be aware of any special restrictions t

233 Clinicians should be aware of SSPE in patients with comp

234 Clinicians should be aware of the risk of allosensitizat

235 Surgeons and other clinicians should be aware of these changes in clinical

236 Clinicians should be aware that M. hominis can cause sur

237 Clinicians should be aware that respiratory health often

238 When considering intensive BP control, clinicians should carefully weigh benefits against poten

239 s in potentially exposed adults suggest that clinicians should consider IgM antibody or polymerase ch

240 ange of medical and surgical conditions, and clinicians should consider the possibility of infection

241 Clinicians should consider the risk of perforation and c

242 Recommendation 6: ACP recommends that clinicians should make the decision whether to treat ost

243 and achieved unanimity on how critical care clinicians should manage conscientious objections relate

244 Clinicians should remain vigilant for signs of poxvirus

245 They concluded that clinicians should reserve antibiotic treatment for acute

246 Best Practice Advice 4: Clinicians should screen all potential EBT candidates wi

247 Clinicians should thus be cognizant of CAD in younger wo

248 Clinicians should understand the importance of prompt re

249 or has negative or unknown PD-L1 expression, clinicians should use nivolumab or atezolizumab.

250 SCLC tumor is positive for PD-L1 expression, clinicians should use single-agent nivolumab, pembrolizu

251 emained a prime focus amongst scientists and clinicians since long, not only to understand the compli

252 e management of HTS has been challenging for clinicians, since current therapies are minimally effect

253 (2 overviews); timing (5 reviews/overviews); clinician skepticism (5 reviews/overviews); clinician kn

254 Baseline clinician staffing included residents (n = 9), fellows (

255 Cardiac surgery ICU characteristics and clinician staffing patterns have not been well character

256 ng of the biology of weight regulation, many clinicians still believe that patients with obesity shou

257 er of choices for testing for the practicing clinician to navigate.

258 To give an additional tool to clinicians to allow both treatment of the tumor and impr

259 te the research of both basic scientists and clinicians to better understand ADP-ribosylation at the

260 have the potential to assist researchers and clinicians to better understand cardiovascular function.

261 r tests, and management tools used by expert clinicians to care for persons with ME/CFS; 4) collect b

262 These results provide evidence for clinicians to consider with their patients when selectin

263 ing is easy to administer and may be used by clinicians to decide further biomarker testing, preventi

264 onic insomnia, there is a paucity of trained clinicians to deliver this much needed treatment.

265 sessment of Cardiovascular Risk" by allowing clinicians to estimate baseline and updated 10-year ASCV

266 Our study may allow clinicians to estimate how VF results are affected by va

267 interpretation and would be available to all clinicians to help direct therapy.

268 propose a practical treatment algorithm for clinicians to help manage this patient population.

269 In this setting, a MELD score >/=18 may help clinicians to identify those patients with a higher risk

270 n detail is cumbersome and confusing for the clinicians to interpret.

271 kidney transplantation requires patients and clinicians to weigh the benefits and harms of a broad ra

272 With the exception of clinician training in communication skills, evidence for

273 Recommendation 2: ACP recommends that clinicians treat osteoporotic women with pharmacologic t

274 Clinicians treating older patients with bipolar disorder

275 Other clinicians tried various methods of creating intralumina

276 This Users' Guide will help clinicians understand the available metrics for assessin

277 those who received usual care consulted a PC clinician upon request.

278 DATA EXTRACTION: Clinicians use ICU length of stay predictions for planni

279 patient-clinician relationship, patient and clinician well-being, and family well-being.

280 Patients and clinicians were aware of group allocation, but allocatio

281 Women and clinicians were blinded to results unless cervical short

282 Clinicians were blinded to whether parents had received

283 Clinicians were masked to neonatal interstitial glucose

284 Patients, investigators, and clinicians were masked to treatment assignment.

285 and intensity of high-cost imaging use, and clinicians were provided with regular comparative feedba

286 not be a key discriminator for patients and clinicians when choosing between non-biologic systemic t

287 taught by a Tanzanian pastor and a Tanzanian clinician who worked with the Ministry of Health, and me

288 In particular, clinicians who care for HCT survivors should be aware of

289 tradeoffs are often difficult reconcile for clinicians who care for patients awaiting liver transpla

290 ement of the informal sector and lower-level clinicians will improve the efficiency and timeliness of

291 romoted for cardiovascular health to provide clinicians with accurate information for patient discuss

292 of pulmonary artery (PA) pressures provides clinicians with actionable information to help further o

293 dard, culture-based diagnostics, can provide clinicians with comprehensive diagnostic information inc

294 Few data are available to assist clinicians with decisions regarding long-term use of ast

295 correlate with the type of variant will help clinicians with diagnosis and prognosis when treating ne

296 To provide ICU clinicians with evidence-based guidance on safe medicati

297 To provide ICU clinicians with evidence-based guidance on tested interv

298 This study provides clinicians with population-based, unbiased data to couns

299 Clinicians without expertise in genetic testing will ben

300 Three thousand three hundred twenty-five clinicians working in 77 ICUs returned questionnaires.